SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-18-000055
Filing Date
2018-11-09
Accepted
2018-11-09 16:41:57
Documents
80
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20180930x10q.htm 10-Q 2118234
2 EX-31.1 kdmn-20180930xex31_1.htm EX-31.1 20714
3 EX-32.1 kdmn-20180930xex32_1.htm EX-32.1 10954
  Complete submission text file 0001557142-18-000055.txt   9595615

Data Files

Seq Description Document Type Size
4 EX-101.INS kdmn-20180930.xml EX-101.INS 2329318
5 EX-101.SCH kdmn-20180930.xsd EX-101.SCH 57235
6 EX-101.CAL kdmn-20180930_cal.xml EX-101.CAL 71805
7 EX-101.DEF kdmn-20180930_def.xml EX-101.DEF 311514
8 EX-101.LAB kdmn-20180930_lab.xml EX-101.LAB 440140
9 EX-101.PRE kdmn-20180930_pre.xml EX-101.PRE 469942
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

IRS No.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 181173656
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1